Abstract. Chemokines and their receptors are essential for leukocyte trafficking, and are also involved in cancer metastasis to specific organs. Although the migration of tumor cells into the lymph nodes is an important aspect of cancer, the processes involved are poorly understood. Chemokine receptors CCR7 and CXCR3 have been shown to play an important role in tumor cell migration and lymph node metastasis. Therefore, the assessment of chemokine receptor expression on lung adenocarcinomas may improve the prediction of the spread of this carcinoma to the lymph nodes. In this study, we examined the expression and function of these two chemokine receptors (CCR7 and CXCR3) in lung adenocarcinoma. By using flow cytometry, they were detected in all of the lung adenocarcinoma cell lines examined. In the chemotaxis assays, A549 cells exhibited CCL21-induced migration, which was significantly suppressed by neutralizing anti-CCR7 antibody. The CXCL10-induced migration of A549 cells was also significantly suppressed by neutralizing anti-CXCR3 antibody. In clinical lung adenocarcinoma samples, we found the expression of CCR7 and CXCR3 in 65 and 90% cases, respectively, most of which had lymph node metastasis. Importantly, the expression of CCR7 was significantly associated with lymph node metastasis, although the expression of CXCR3 was not. These results suggest that the activation of CCR7 and CXCR3 with their ligands preferentially stimulates lung adenocarcinoma metastasis to the draining lymph nodes.
Introduction
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide, and its incidence and mortality rate continue to rise. The poor prognosis of NSCLC is mediated in part by the specific and aggressive metastatic pattern of the primary cancer cells to regional lymph nodes, contralateral lung, brain, liver, adrenal glands and the bone marrow (1) (2) (3) (4) . The preference for the cells to metastasize to specific organs may depend on a variety of factors (5, 6) . According to Liotta et al (7) , while all the migrating carcinoma cells have the ability to invade any tissue, they only metastasize if all requirements for their growth are met. Other researchers have suggested that tissue-specific adhesion molecules on endothelial cells select migrating carcinoma cells which attach to the adhesion molecules, resulting in the development of a premetastatic nucleus of cells (8) . Another theory proposes that chemoattractants, produced by stromal or immune cells, attract invasive cancer cells to tissues where they have potential for secondary growth (9) . Previous studies have shown the involvement of chemokine receptors in cancer metastasis (10) (11) (12) .
The chemokine family are one of small molecular weight (8-14 kDa) chemotactic cytokines that bind to G-proteincoupled heptahelical receptors, an action which plays a pivotal role in the regulation of leukocyte trafficking and their extravasation through the luminal surface of endothelial cells into sites of tissue inflammation (13) (14) (15) . Chemokine ligands CCL19 and CCL21, which are constitutively expressed by lymph node cells and other immune cells, share a common chemokine receptor, CCR7 (11) . It has been reported that one of these CCR7 ligands (CCL21) can bind to, and activate, the chemokine receptor CXCR3 in mice (16) .CCL19 and CCL21 share CXCR3 with two other chemokine ligands CXCL9 and CXCL10, which are also constitutively expressed by lymph nodes (17, 18) . On the other hand, the chemokine receptor CCR7 is essential for the recruitment to the lymph nodes of naïve T, certain memory T and mature dendritic cells, and for the retention of Th1 lymphocytes within lymph nodes (19, 20) . Similarly, the chemokine receptor CXCR3 plays a central role in the recruitment of plasmacytoid dendritic cell precursors, monocytes and natural killer cells to the inflamed lymph nodes ONCOLOGY REPORTS 19: 1461 -1468 , 2008 Association between the expression of chemokine receptors CCR7 and CXCR3, and lymph node metastatic potential in lung adenocarcinoma SHINICHI MAEKAWA 1 , AKINORI IWASAKI 1 , TAKAYUKI SHIRAKUSA 1 , (21) (22) (23) . Regarding the direct role of chemokines in lymph node metastasis, previous reports suggest a critical role for the chemokine receptors CCR7 and CXCR3 in the metastasis of melanoma and breast cancer (12, 18, 24) . In this study, we demonstrate that CCR7 and CXCR3 are expressed by human lung adenocarcinoma cell lines and primary T1 lung adenocarcinoma tissues and that they play a key role in lung adenocarcinoma metastasis to the lymph nodes. Our results also suggest that CCR7 and CXCR3 are potential novel therapeutic targets that suppress lymph node metastasis in lung adenocarcinoma.
Materials and methods
Cell lines. The lung adenocarcinoma cell lines A549, NCI-H838, NCI-H1395 and NCI-H1650 were obtained from the American Type Culture Collection (Manassas, VA, USA). The lung adenocarcinoma cell lines HLC-1 and RERF-LC-KJ were obtained from RIKEN cell bank (Tsukuba, Ibaragi, Japan). Cells were cultured in RPMI-1640 medium (Sigma-Aldrich, St. Louis, MO, USA), supplemented with 10% heat-inactivated fetal bovine serum (FBS) (Bio Whittaker, Walkersville, MD, USA), 100 U/ml penicillin G and 100 mg/ml streptomycin (Invitrogen, Carlsbad, CA, USA). Chemotaxis assay. Cell migration was determined using a modified Boyden chamber assay as previously described (26) . Briefly, the Chemicon QCM 96-well cell migration assay kit (Chemicon, Temecula, CA, USA) with an 8-μm pore size was run three times. Cells were briefly trypsinized and adjusted to 1x10 6 cells/ml in RPMI-1640 medium, which contained 1% FBS (Bio Whittaker). Ligands of the chemokine receptors CCR7, CCL21 and CCL19 (R&D Systems), and a ligand of the chemokine receptors CXCR3 and CXCL10 (R&D Systems) were dissolved in the medium to various concentrations. After the different concentrations of CCL21, CCL19 and CXCL10 had been added to the lower chamber as attractants, the cells (1x10 3 cells/ml) were applied to the upper chamber on the top of the membrane. In neutralization studies, the cells were incubated with the various concentrations of either anti-human CCR7 or anti-human CXCR3 antibody (R&D Systems) for 2 h at 4˚C before being used in the chemotaxis assays. After 18 h of incubation at 37˚C in a CO 2 incubator, the migratory cells on the bottom of the inserted membrane were dissociated from it by incubation with a cell detachment buffer. The cells were subsequently lysed and stained with CyQuant GR dye (Chemicon), which exhibits strong fluorescence enhancement when bound to cellular nucleic acids, and the fluorescence was measured with a fluorescence plate reader with a 480/520 nm filter set.
Time-lapse images of the lung adenocarcinoma cell line during chemotaxis were obtained using EZ-TAXIScan™ (GE Healthcare, Tokyo, Japan) as previously described (27) . The lung adenocarcinoma cells (5x10 3 cells/ml) were injected into one of the two compartments through a hole connected to that compartment. To adjust for the position of the cells, the medium was drawn out through the hole connected to the opposite compartment. This process was stopped when the cells were aligned in the channel close to the edge. Aliquots of various concentrations of CCL21 (1 μl) were then injected into the other compartment to initiate chemotaxis and monitoring began. The images of the channels were recorded, digitally, channel by channel onto a computer hard disk at time-lapse intervals with a high performance lens connected to a CCD camera and a coaxial episcopic illumination system.
Immunohistochemistry. Immunohistochemical staining using the dextran polymer method was used to assess CCR7 and CXCR3. Briefly, paraffin-embedded 5 μm sections obtained from surgical specimens fixed in 10% formalin were de-waxed in xylene and dehydrated through graded concentrations of ethanol. Endogenous peroxidase was blocked by incubation in a peroxidase blocking solution (S2023, Dako Cytomation, Kyoto, Japan). Antigen retrieval was performed for 10 min at 95˚C in a microwave. After these procedures, the sections were washed in TBST (50 mM Tris-HCl buffer, pH 7.6, including 0.1% Tween-20 and 0.15 M NaCl) for 5 min, followed by incubation with the primary antibodies for CCR7 and CXCR3 at 1:100 dilutions for 30 min. After washing three times with TBST, the sections were incubated with Envision + (K4000, Dako Cytomation) for 30 min in a humidified box at room temperature. The sections were washed again three times in TBST for 5 min, developed with DAB + (K3467, Dako Cytomation) for 5 min and counterstained with hematoxylin solution for 1 min.
We interpreted a sample as positive for CCR7 or CXCR3 when >10% of the tumor cells were stained with either antibody.
Statistical analysis. Data were expressed as the mean ± standard deviation (SD) of repeated assays. Statistical differences between the two groups were evaluated using the 
Results

Expression of chemokine receptors CCR7 and CXCR3 in lung adenocarcinoma cell lines.
We performed flow cytometry to analyze the expression of CCR7 and CXCR3 proteins in six human lung adenocarcinoma cell lines. As shown in Fig. 1 , the lung adenocarcinoma cell lines (HLC-1, RERF-LC-KJ, A549, NCI-H838, NCI-H1395 and NCI-H1650) expressed CCR7 (panel A) and CXCR3 (panel B). Since A549 cells exhibited the same levels of CCR7 and CXCR3 expression, we used this cell line as our model of CCR7-and CXCR3-expressing lung adenocarcinoma in the subsequent experiments.
CCR7-and CXCR3-mediated cellular responses of A549 cells in vitro.
To determine whether CCR7 expressed by lung adenocarcinoma cells was functional, we examined the chemotactic responses of A549 cells to CCL21. As shown in Fig. 2A , A549 cells showed a significant chemotactic response to CCL21 in a typical bell-shaped dose-dependent manner. Furthermore, the neutralizing anti-CCR7 antibody significantly suppressed the migratory response in a dose-dependent manner ( Fig. 2A) . It has been reported that one of the CCR7 ligands, CCL21, can bind to and activate CXCR3 in mice (16) , and that CCL21 is a functional ligand for endogenously expressed CXCR3 (28) . Therefore, we investigated whether the cocktail of the neutralizing anti-CXCR3 and anti-CCR7 
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antibodies inhibit the CCL21-induced migration. Fig. 2A shows that the cocktail suppressed the CCL21-induced migration more than the neutralizing anti-CCR7 antibody alone, although the differences were not statistically significant. Along with CCL21, we examined the chemotactic responses of A549 cells to CCL19, but significant differences were not observed (data not shown). We then examined the chemotactic responses of A549 cells to CXCL10. As shown in Fig. 2B , A549 cells showed significant chemotactic responses to CXCL10 in a bell-shaped dose-dependent manner. The neutralizing anti-CXCR3 antibody significantly inhibited the migratory response in a dose-dependent manner (Fig. 2B) .
Furthermore, the cells were imaged every 3 min by using EZ-TAXIScan. Fig. 3 shows images of the migration of A549 cells following exposure to CCL21, as observed by EZ-TAXIScan. The chemokine-stimulated A549 cells began to migrate one by one towards the other end of the channel where the concentration of the chemokine was highest. To examine the clinical relevance of the expression of CCR7 and CXCR3, we immunohistochemically examined specimens from 20 lung adenocarcinoma patients. We found that 13 of the samples (65.0%) expressed CCR7 in cancerous epithelial cells, whereas 18 (90.0%) expressed CXCR3 and 2 samples expressed neither CCR7 nor CXCR3. The CCR7 and CXCR3 proteins were detected in the plasma membrane and cytoplasm of the cancer cells (Fig. 4A and B) but not in the normal lung epithelial cells. The expression of CCR7 was significantly associated with lymph node metastasis (Table I) , whereas there was no significant correlation between the expression of CXCR3 and lymph node metastasis. Cancer cells metastasized to lymph nodes in 9 out of the 13 (69.2%) cases 
CCR7 and CXCR3 expression and the correlation between chemokine receptor expression levels and lymph node
A B
that expressed CCR7 but did not in 1 out of the 7 (14.3%) cases that showed no CCR7 expression.
Discussion
In this article we examined the CCR7-and CXCR3-mediated cellular responses of lung adenocarcinoma cell lines and the correlation between lymph node metastasis and the expression of CCR7 or CXCR3 in human primary T1 lung adenocarcinoma. Takanami et al (10) previously demonstrated that, in NSCLC patients, the CCR7 mRNA expression was significantly associated with lymph node metastasis, tumor stage, lymphatic invasion and the expression of CCR7 and CXCR4 proteins. However, our present report demonstrated that CXCR3, as well as CCR7, are expressed in lung adenocarcinoma cell lines, thus suggesting that CCR7 and CXCR3 play a role in lung adenocarcinoma metastasis to lymph nodes. The expression of CCR7 and CXCR3 was found in the six lung adenocarcinoma cell lines tested. To characterize their role in the migration of cancer cells, we used the migration assay and the real-time chemotaxis assay system EZTAXIScan, which is able to visualize cell migration. Results obtained with this assay suggested a functional interaction between the chemokine receptor CCR7 and its ligand CCL21 in A549 cells. Tumor cells use chemokine-mediated mechanisms, such as the regulation of leukocyte trafficking, during the process of metastasis (29) . Cancerous epithelial cells undergo clonal proliferation, invade local tissues, induce angiogenesis and express CCR7 on their surface (29) . Two constitutively expressed chemokines, CCL21 and CCL19, have been shown to be abundant in lymph nodes (14) and are, therefore, likely candidates for attracting CCR7-expressed tumor cells to the regional lymph nodes. Previous studies (30, 31) showed that CCL21 is produced by lymphatic endothelial cells as well as lymph nodes. The migration of malignant cells from peripheral tissue into the lymphatic system may be an active process mediated by the interaction between CCL21 and CCR7. Our results from the in vitro experiments indicated that the functional CCR7 is expressed in lung adenocarcinoma cells and may be relevant to the process by which these cells preferentially migrate to lymph nodes where they will subsequently metastasize. Moreover, we showed that 65% of lung adenocarcinoma tissues expressed CCR7 and found a significant correlation between the expression of CCR7 and lymph node metastasis. These findings were in keeping with those of other studies (30, 32, 33) . Studies have found that the chemokine receptor CXCR3 was highly expressed in melanoma and breast carcinomas, and the interaction between this receptor and its ligand, CXCL10, resulted in chemotaxis or the directed migration of tumor cells from their primary site via the circulation to preferential sites of metastasis (12, 18, 24) . In the present study, we also demonstrated that CXCL10 induced lung cancer cell migration. Importantly, CCR7 and CXCR3 are involved in the recruitment and patterning of several types of immune cells to the lymph nodes, suggesting that tumor cells have acquired these receptors and are controlled by their ligands in a manner similar to the immune cell interactions. We have confirmed herein that the CCR7 ligand CCL21 is also functional for CXCR3 in human lung adenocarcinoma cells. Although in this study there was no significant correlation between the expression of CXCR3 in the primary lung adenocarcinoma tissues and lymph node metastasis, our present findings suggest that CXCR3 is involved in the metastasis of lung adenocarcinoma cells.
Notably, the level of expression of CCR7 and CXCR3 proteins was higher in the lung cancer cells that invaded the stroma than in those that did not, and CXCR3 protein was likely to be expressed earlier than the CCR7 protein in the process of cancer development (data not shown). Kawakami et al (34) demonstrated that the degree of stromal invasion correlates with prognosis even in pT1 lung adenocarcinoma. Thus, the expression of these receptors may influence the stromal invasion and prognosis in pT1 lung adenocarcinoma. Further investigation will be needed to clarify the detailed relationships between the stromal invasion, prognosis and the expression of these receptors.
A complex network of chemokines and their receptors influences the development of the primary tumors and their metastatic foci. There are two aspects to the biological role of chemokines in these processes: their role in controlling leukocyte infiltration in cancer, and their influence on the metastatic potential and site-specific spread of tumor cells (35) . It has been demonstrated that CCL21 and CXCL10 exert antitumor activities by inducing immune-stimulating and angiostatic effects (36, 37) . Notably, CCL21 and CXCL10 play additional roles in the tumor micro-environment (17, 18, 24, 38, 39) .
In conclusion, these findings and those of previous studies suggest that CCR7 and CXCR3 play a critical role in lung adenocarcinoma cell metastasis to lymph nodes by inducing cell migration. Recently, several antagonists of chemokine receptors have been identified (28, 40) . Our results also suggest that an antagonist of CCR7 and/or CXCR3 is useful in controlling lymph node metastasis by lung adenocarcinoma cells. Table I . Significant correlations between CCR7 expression in lung adenocarcinoma and lymph node metastasis.
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